SBFM Stock Analysis: Buy, Sell, or Hold?
SBFM - Sunshine Biopharma Inc.
$1.16
0.00 (0.00%)
â˛
5d:
+3.57%
30d:
-30.12%
90d:
+141.01%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When SBFM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SBFM is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SBFM is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SBFM is currently trading at $1.16, which is considered slightly low relative to its 30-day fair value range of $1.12 to $1.61. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.9) compared to its historical average (13.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SBFM is in a uptrend. Immediate support is located at $1.03, while resistance sits at $1.25.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $56.00 (+4727.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SBFM is in a uptrend. Immediate support is located at $1.03, while resistance sits at $1.25.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $56.00 (+4727.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.12 -
$1.61
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: Trading 4727.6% below Wall St target ($56.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.12 -
$1.61
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.03
Resistance Level
$1.25
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.90
Wall Street Target
$56.00
(+4727.6%)
Revenue Growth (YoY)
-1.6%
Profit Margin
-16.5%
PE vs Historical
-2.9 vs 13.1
CHEAP
Share & Embed Analysis
Last updated: August 24, 2026 8:48 PM ET
Data refreshes hourly during market hours. Next update: 9:48 PM
Data refreshes hourly during market hours. Next update: 9:48 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBFM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 54 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 50 HOLD |
|
UTHR
United Therapeutics CorpâĻ |
STRONG BUY
15 analysts |
$664 | 49 HOLD |
|
BCRX
BioCryst PharmaceuticalsâĻ |
STRONG BUY
12 analysts |
$21 | 50 HOLD |